Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 April 2007, Vol. 109, No. 8, pp. 3342-3350.
Prepublished online as a Blood First Edition Paper on December 19, 2006; DOI 10.1182/blood-2006-09-046698.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Table and Figures
Right arrow All Versions of this Article:
blood-2006-09-046698v1
109/8/3342    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomas, M.
Right arrow Articles by Allman, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomas, M.
Right arrow Articles by Allman, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted September 11, 2006
Accepted December 2, 2006

Notch activity synergizes with B cell receptor and CD40 signaling to enhance B cell activation

Matthew Thomas, Marco Calamito, Bhaskar Srivastava, Ivan Maillard, Warren S Pear, and David Allman*

Dept of Pathology & Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA
Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, Philadelphia, PA
Institute for Medicine & Engineering, University of Pennsylvania School of Medicine, Philadelphia, PA

* Corresponding author; email: dallman{at}mail.med.upenn.edu.

How diverse environmental cues are integrated to regulate B cell activation and development remains poorly understood. Here we show that Notch activity synergizes with B cell receptor and/or CD40 signaling to enhance several aspects of B cell activation and function. We find that co-stimulation of follicular B cells with the Notch ligand Delta-like-1 leads to significant increases in BCR- and CD40-mediated proliferation, and enhances production of IgG1+ cells in vitro and in vivo. We further find that co-engagement of Notch and the BCR results in increased activation of the MAPK pathway, and MAPK and Notch inhibitors prevent B cell activation events mediated by co-engagement of Notch and the BCR. These data suggest that the BCR and CD40 signaling pathways collaborate with the Notch pathway to optimize B cell activation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. A. Santos, L. M. Sarmento, M. Rebelo, A. A. Doce, I. Maillard, A. Dumortier, H. Neves, F. Radtke, W. S. Pear, L. Parreira, et al.
Notch1 engagement by Delta-like-1 promotes differentiation of B lymphocytes to antibody-secreting cells
PNAS, September 25, 2007; 104(39): 15454 - 15459.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020